LobbyingAssociation of Accessible Medicines lobbying by quarter
Association of Accessible Medicines's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Association of Accessible Medicines
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $180K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $90K | 2 |
| Q1 2023 | $50K | 1 |
| Q2 2023 | $50K | 1 |
| Q3 2023 | $50K | 1 |
| Q4 2023 | $50K | 1 |
| Q1 2024 | $60K | 2 |
| Q2 2024 | $90K | 2 |
| Q3 2024 | $90K | 2 |
| Q4 2024 | $90K | 2 |
| Q1 2025 | $100K | 2 |
| Q2 2025 | $100K | 2 |
| Q3 2025 | $100K | 2 |
| Q4 2025 | $60K | 1 |
| Q1 2026 | $60K | 1 |
| Q2 2026 | $60K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$376.7K · 20 reports
- Medicare and Medicaid$286.7K · 15 reports
- Pharmacy$261.7K · 14 reports
- Copyright, patent and trademark$160K · 9 reports
- Trade$15K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE23 reports
- HOUSE OF REPRESENTATIVES15 reports
- Health & Human Services, Dept of (HHS)10 reports
- Centers For Medicare and Medicaid Services (CMS)9 reports
- Executive Office of the President (EOP)8 reports
- Federal Trade Commission (FTC)1 reports
- Office of Management & Budget (OMB)1 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Mehlman Consulting | $850K | 15 quarters |
| Endgame Strategies | $250K | 8 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| EARL SCOTT FLOOD | Dep. CoS, LD (Rep. Robin Kelly); Health Pol Adv, Csl (Rep. Terri Sewell); Csl (Rep. Cedric Richmond); Pol Aide (Sen. Claire McCaskill) | Q4 2025 |
| JOSEPH EDWARD BROWN iii | Sr Prof Staff (EPW Comm Maj/Sen. Moore Capito); Prof Staff (EPW Comm Min/Ranking Mem Sen. Moore Capito); Leg Asst (Sen. Boozman); Maj Leg Asst (EPW Comm Maj/Sen. Jim Inhofe); Maj Research Asst (EPW Comm Maj/Sen. Jim Inhofe); Intern (Rep. Jim Renacci) | Q3 2025 |
| STEVEN DUFFIELD | Senate Republican Conference (Policy Director); Senate Republican Policy Committee (Deputy Staff Director; Chief Counsel; Judiciary Policy Analyst) | Q3 2025 |
| JON ADAME | CoS, LD, GC (Sen. Blackburn); Counsel (Rep. Blackburn); Policy Coordinator (House E&C); Intern (Sen. Domenici) | Q2 2025 |
| ANNIE WOLF | Dep Floor Dir (Maj Leader Scalise); CoS (Chief Dep Min Whip Ferguson); Dep Floor Dir (Min Whip Scalise); Prof Staff (House Rules/Sessions); Floor Asst (Speakers Ryan & Boehner); Staff Asst (Speaker Boehner); Intern (Rep. Sullivan) | Q3 2024 |
| NAVEEN PARMAR | Chief Counsel (Sen. Hickenlooper); General Counsel (House Comm on Sm Bus/Velazquez); Tax Counsel, (House Comm on Sm Bus/Velazquez); Economic Policy Counsel (Sen. Amy Klobuchar); Ways and Means Counsel (Rep. Lloyd Doggett) | Q3 2024 |
| ALYENE MLINAR | Pol Adv (Maj Leader Scalise); Pol Adv (Min Whip Scalise); Pol Adv (House Oversight/Govt Reform Comm); Prof Staff Member (Ways and Means Subcom on Health/Brady), Pol Adv (Sen Rep Policy Comm/Barrasso); Leg Asst (Senator Ben Sasse) | Q4 2023 |
| ERICA JAY CHABOT | Staff Asst, Leg Corres, Asst Schd, Asst to COS, Press Asst, Dep Press Sec, Leg Dir (Senator Patrick Leahy); Prof Staff (Sen Approp Comm); LD (Sen Pres Pro Temp Emeritus); Dep COS (Senate Consult); Staff Dir (Sen Ag Comm) | Q4 2023 |
| CAITLIN VAN SANT | Sr Pol Adv, Leg Dir, Interim COS (Rep. Butterfield) | Q4 2022 |
| LISA GOLDMAN | Sr Counsel, House Comm on Energy & Commerce; Chief Counsel, Sr Counsel (E&C Subcommittee on Consumer Protection & Commerce); Counsel House Comm on E&C | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Mehlman Consulting | $60K |
| 04/20for Q1 | Mehlman Consulting | $60K |
| 01/20for Q4 2025 | Mehlman Consulting | $60K |
| 25/10/20for Q3 2025 | Mehlman Consulting | $60K |
| 25/09/23for Q3 2025 | Endgame Strategies | $40K |
| 25/07/21for Q2 2025 | Endgame Strategies | $40K |
| 25/07/21for Q2 2025 | Mehlman Consulting | $60K |
| 25/04/17for Q1 2025 | Mehlman Consulting | $60K |
| 25/04/15for Q1 2025 | Endgame Strategies | $40K |
| 25/03/11for Q4 2024 | Mehlman Consulting | $60K |
| 25/03/11for Q3 2024 | Mehlman Consulting | $60K |
| 25/01/20for Q4 2024 | Mehlman Consulting | $60K |
| 25/01/07for Q4 2024 | Endgame Strategies | $30K |
| 24/10/18for Q3 2024 | Mehlman Consulting | $60K |
| 24/10/16for Q3 2024 | Endgame Strategies | $30K |
| 24/07/22for Q2 2024 | Endgame Strategies | $30K |
| 24/07/19for Q2 2024 | Mehlman Consulting | $60K |
| 24/04/19for Q1 2024 | Mehlman Consulting | $50K |
| 24/04/17for Q1 2024 | Endgame Strategies | $10K |
| 24/03/12for Q1 2024 | Endgame Strategies | Under $5,000 |